← Back to all trials
Not Yet Recruiting
NCT05672225
Two-channel IV-PCA With Dexmedetomidine
Conditions: Analgesia, Patient-Controlled, Dexmedetomidine
Sex: All
Ages: 20 Years – N/A
Phase: NA
Enrollment: 110
Sponsor: Korea University Guro Hospital
Summary
Dexmedetomidine was administered in the 'selector' channel and fentanyl in the 'basic & bolus' channel of dual channel intravenous patient-controlled analgesia (IV-PCA) and the amount of opioid consumption was compared.
In addition, intensity of pain, postoperative nausea/vomiting, and postoperative delirium was evaluated.
Eligibility Criteria
Inclusion Criteria:Patients who was scheduled for laparoscopic major abdominal surgery (Gastrectomy, Hepatectomy, Colectomy, Pancreatectomy) under general anesthesiaAged ≥ 20 years oldExclusion Criteria:Body mass index ≥35 kg/m2American Society of Anesthesiologists physical status > 3Severe cardiovascular disorderSevere liver or renal dysfunctionPreoperative dyspneaContraindication to dexmedetomidine (preoperative severe bradycardia (Heart rate <50), atrioventricular block, allergy to dexmedetomidine)Preoperative use of opioid, anticonvulsant, antidepressant
Source: ClinicalTrials.gov (NCT05672225). StuddyBuddy aggregates publicly available trial information.
